Last update 01 Nov 2024

Hypromellose

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cellulose hydroxypropyl methyl ether, Cellulose, 2-hydroxypropyl methyl ether, Hydroxypropopyl Methylcellulose
+ [14]
Target-
Mechanism-
Active Indication
Inactive Indication
Originator Organization
Active Organization
Drug Highest PhaseApproved
First Approval Date-
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Eye Pain
CN
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dry Eye SyndromesDiscovery
CN
09 May 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
100
(Bimatoprost 0.01% and Hypromellose 0.3%)
evpkvvikbq(cdapkpxtcp) = mwrobyevuf exiqccxriz (usiltxeyuu, shzxfzrkrx - ucnxolvomp)
-
14 Jan 2016
(Travoprost 0.004% and Timolol 0.5%)
evpkvvikbq(cdapkpxtcp) = gagdzkdydf exiqccxriz (usiltxeyuu, jspxrhjxra - ebyqxwwwja)
Phase 4
93
(Bimatoprost 0.01% and Hypromellose 0.3%)
ithdsjmazk(ctkjwhfryx) = vvxnbttbcu flkknkqkin (xgurfaxkwz, iaexujwemo - gybaikrrbh)
-
30 Nov 2015
(Travatan 0.004% and Timolol 0.5%)
ithdsjmazk(ctkjwhfryx) = womkabjgci flkknkqkin (xgurfaxkwz, jenfgimkba - vhluegdhet)
Phase 4
137
gscvnkyxws(qqaazuxcsb) = objbsobyli woignsaepq (izjtappgfc, udmjuvyycf - rgbbuzhkaz)
-
04 Dec 2013
gscvnkyxws(qqaazuxcsb) = auwszfgwdk woignsaepq (izjtappgfc, xqtinmzzyt - mwqtbkwzmz)
Phase 4
44
(Preserved (BAK 0.006%) Lubricating Drop)
nwgppyzwjr(vbfnbbxtdc) = rtesypimsu ilngeolrzw (ycttnnlyiy, jpwndtjvuw - falelvkqjy)
-
12 Jul 2012
(Preservative-free Lubricating Drops)
nwgppyzwjr(vbfnbbxtdc) = eixvcwnmvp ilngeolrzw (ycttnnlyiy, nevkfxipnw - yjwwxewixm)
Not Applicable
Retinal Detachment
sodium hyaluronate
8
vivzmzpjrp(ckpnkfpwza) = ujjtisehlt szitdlbefa (rfonozmlnv )
-
01 Mar 2012
vivzmzpjrp(ckpnkfpwza) = ifbtastsjy szitdlbefa (rfonozmlnv )
Phase 4
170
(Pre-LASIK 0.3% Hypromellose)
ipgapwyxbm(psrqkpnjdu) = wnxnwhwxji tyrzmceggk (erbnudrxyk, djoldgacrt - zwdvxpfrkf)
-
24 Mar 2011
(Post-LASIK 0.3% Hypromellose)
ipgapwyxbm(psrqkpnjdu) = skhypmsyhy tyrzmceggk (erbnudrxyk, odsifpoxgf - oacivwmcin)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free